|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,835.00 KRW | +7.27% |
|
-19.18% | -44.26% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-03 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 24/06/2026 | 25/06/2026 | 26/06/2026 | 29/06/2026 | Today | |
|---|---|---|---|---|---|
| Last | ₩4,455.00 | ₩3,965.00 | ₩3,575.00 | ₩3,835.00 | ₩3,860.00 |
| Volume | 310,610 | 728,934 | 671,441 | 693,499 | 428,536 |
| Change | +2.89% | -11.00% | -9.84% | +7.27% | +0.65% |
| Opening | ₩4,330.00 | ₩4,455.00 | ₩3,900.00 | ₩3,520.00 | ₩3,835.00 |
| High | ₩4,590.00 | ₩4,545.00 | ₩3,950.00 | ₩3,975.00 | ₩4,100.00 |
| Low | ₩4,250.00 | ₩3,810.00 | ₩3,510.00 | ₩3,520.00 | ₩3,620.00 |
Performance
| 1 day | +7.27% | ||
| 1 week | -19.18% | ||
| Current month | -37.34% | ||
| 1 month | -37.34% | ||
| 3 months | -59.97% | ||
| 6 months | -45.21% | ||
| Current year | -44.26% | ||
| 1 year | +35.04% | ||
| 3 years | -54.56% | ||
| 5 years | -80.53% |
Volumes
marketsDaily volume
693,499
Avg. Volume 20 sessions
593,784
Avg. Volume 20 sessions KRW
2,277,161,640
Avg. Volume 20 sessions USD
1,468,769.26
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Market Cap (KRW)
173,258,216,434
Market Cap (USD)
112,306,247
Net sales ()
24,586,847,080
Net sales (USD)
15,937,233
Free-Float
82.63 %
Free-Float capitalization (KRW)
143,363,601,438
Free-Float capitalization (USD)
92,928,511
Average Daily Capital Traded
1.31%
Indicators
Moving average 5 days
4,032
Moving average 20 days
5,085.75
Moving average 50 days
5,977.7
Moving average 100 days
6,876.25
Price spread / (MMA5)
+5.14%
Price spread / (MMA20)
+32.61%
Price spread / (MMA50)
+55.87%
Price spread / (MMA100)
+79.30%
RSI 9 days
29.35
RSI 14 days
32.56
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.27% | -19.18% | +35.04% | -54.56% | 112M | |
| +1.17% | +5.82% | -3.50% | +2.21% | 46.62B | |
| -1.25% | +11.85% | +415.33% | +608.75% | 40.95B | |
| +0.05% | +12.57% | +22.35% | -14.22% | 32.26B | |
| -1.32% | +3.55% | +18.11% | +60.36% | 32.24B | |
| +8.02% | +6.35% | +17.67% | +34.73% | 25.53B | |
| +1.39% | +11.40% | - | - | 16.38B | |
| +0.12% | +12.91% | +70.33% | +122.59% | 15.27B | |
| +0.12% | +4.69% | +13.00% | +17.43% | 13.61B | |
| -1.52% | +4.78% | +101.52% | +94.05% | 13.34B | |
| Average | +1.39% | +9.28% | +76.65% | +96.82% | 23.63B | |
| Weighted average by Cap. | +0.73% | +11.57% | +96.44% | +139.88% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 3,510 |  | 4,590 |
| 1 month | 3,510 | | 6,130 |
| Current year | 3,510 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -43.90% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
